Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06091007 · ClinicalTrials.gov registry record · NA
Magnesium Citrate Supplementation on Hand Grip Strength
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT06091007: Completed NA study, sponsored by Loma Linda University.
NCT06091007 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06091007, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine the effectiveness of magnesium on handgrip strength using the more bioavailable magnesium citrate.
Primary Outcome
Participants will perform three separate handgrip strength tests using a Jamar Plus digital hand dynamometer, (Sammons Preston, Bolingbrook, Illinois). In each test, participants will do three trials resting for 15 seconds between trials, the average of the three trials will be recorded. To perform the hand grip strength test, the participant will hold the dynamometer in their dominant hand, with the arm at a right angle, and with the elbow by the side of the body. The participant then squeezes
Interventions
- DIETARY_SUPPLEMENT Magnesium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2023-11-17 |
| Est. Completion | 2024-02-29 |
| Phase | NA |
What the finished NCT06091007 record still lists
NCT06091007 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Magnesium is the first listed.
NCT06091007 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06091007 about?
NCT06091007 is a clinical study titled "Magnesium Citrate Supplementation on Hand Grip Strength". The purpose of this research study is to determine the effectiveness of magnesium on handgrip strength using the more bioavailable magnesium citrate.
What is the current status of trial NCT06091007?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2023-11-17. Estimated completion is 2024-02-29.
What interventions are being tested in trial NCT06091007?
The interventions under investigation include: Magnesium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06091007?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06091007's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI